Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 20;108(4):djv351.
doi: 10.1093/jnci/djv351. Print 2016 Apr.

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories

Victoria M Raymond  1 , Stacy W Gray  1 , Sameek Roychowdhury  1 , Steve Joffe  1 , Arul M Chinnaiyan  1 , D Williams Parsons  1 , Sharon E Plon  1 ; Clinical Sequencing Exploratory Research Consortium Tumor Working Group
Collaborators, Affiliations

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories

Victoria M Raymond et al. J Natl Cancer Inst. .

Abstract

Precision oncology holds great potential to improve patient therapies and outcomes. Tumor sequencing is rapidly moving into clinical care as our understanding of the cancer genome and the availability of targeted therapies increase. Analysis of the cancer genome is most informative when paired with germline genomic DNA to delineate inherited and somatic variants. Although tumor-only analysis remains the most common methodology for numerous reasons, it holds the potential to identify clinically significant germline variants. Here, we provide anticipatory guidance and points to consider for laboratories and clinicians regarding the potential for germline findings in tumor sequencing.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Roychowdhury S, Iyer MK, Robinson DR, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011;3(111):111ra121. - PMC - PubMed
    1. Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol. 2013;31 (15):1806–1814. - PubMed
    1. Mody RJ, Wu Y-M, Lonigro RJ, et al. Use of Integrative Clinical Sequencing in the Management of Pediatric Cancer Patients. J Am Med Assoc. 2015;314 (9):1–13. - PMC - PubMed
    1. Hammond MEH, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28 (16):2784–2795. - PMC - PubMed
    1. Wolff AC, Hammond MEH, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31 (31):3997–4013. - PubMed

Publication types